An Integrated Safety Profile Analysis of Belatacept in Kidney Transplant Recipients Grinyó, Josep; Charpentier, Bernard; Pestana, José Medina; More Grinyó, Josep; Charpentier, Bernard; Pestana, José Medina; Vanrenterghem, Yves; Vincenti, Flavio; Reyes-Acevedo, Rafael; Apanovitch, Anne Marie; Gujrathi, Sheila; Agarwal, Mamta; Thomas, Dolca; Larsen, Christian P. Less Transplantation. 90(12):1521-1527, December 27, 2010. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies Larsen, Christian P.; Grinyó, Josep; Medina-Pestana, José; More Larsen, Christian P.; Grinyó, Josep; Medina-Pestana, José; Vanrenterghem, Yves; Vincenti, Flavio; Breshahan, Barbara; Campistol, Josep M.; Florman, Sander; Rial, Maria del Carmen; Kamar, Nassim; Block, Alan; Di Russo, Gregory; Lin, Chen-Sheng; Garg, Pushkal; Charpentier, Bernard Less Transplantation. 90(12):1528-1535, December 27, 2010. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
Islet Transplantation in Type 1 Diabetic Patients Using Calcineurin Inhibitor-Free Immunosuppressive Protocols Based on T-Cell Adhesion or Costimulation Blockade Posselt, Andrew M.; Szot, Gregory L.; Frassetto, Lynda A.; More Posselt, Andrew M.; Szot, Gregory L.; Frassetto, Lynda A.; Masharani, Umesh; Tavakol, Mehdi; Amin, Raj; McElroy, Joan; Ramos, Marissa D.; Kerlan, Robert K.; Fong, Lawrence; Vincenti, Flavio; Bluestone, Jeffrey A.; Stock, Peter G. Less Transplantation. 90(12):1595-1601, December 27, 2010. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
Low Serum Mannose-Binding Lectin as a Risk Factor for New Onset Diabetes Mellitus After Renal Transplantation Ibernon, Meritxell; Moreso, Francesc; Moreno, José M.; More Ibernon, Meritxell; Moreso, Francesc; Moreno, José M.; Bestard, Oriol; Cruzado, Josep M.; Grinyó, Josep M.; Ricart, Wifredo; Fernández-Real, José M.; Serón, Daniel Less Transplantation. 88(2):272-278, July 27, 2009. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
Belatacept as Immunosuppression in Patient With Recurrence of Hemolytic Uremic Syndrome After Renal Transplantation Midtvedt, Karsten; Bitter, Jan; Dørje, Christina; More Midtvedt, Karsten; Bitter, Jan; Dørje, Christina; Bjørneklett, Rune; Holdaas, Hallvard Less Transplantation. 87(12):1901-1903, June 27, 2009. Favorites PDF Get Content & Permissions Free
Assessment of Belatacept-Mediated Costimulation Blockade Through Evaluation of CD80/86-Receptor Saturation Latek, Robert; Fleener, Catherine; Lamian, Vahideh; More Latek, Robert; Fleener, Catherine; Lamian, Vahideh; Kulbokas, Edward III; Davis, Patricia M.; Suchard, Suzanne J.; Curran, Mark; Vincenti, Flavio; Townsend, Robert Less Transplantation. 87(6):926-933, March 27, 2009. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
Fibrogenesis in Kidney Transplantation: Potential Targets for Prevention and Therapy Djamali, Arjang; Samaniego, Millie Djamali, Arjang; Samaniego, Millie Less Transplantation. 88(10):1149-1156, November 27, 2009. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
A MIXED TREATMENT COMPARISON OF EFFICACY AND CARDIOMETABOLIC SAFETY OF BELATACEPT, CYCLOSPORINE AND TACROLIMUS FOR IMMUNOSUPPRESSION THERAPY IN ADULT RENAL TRANSPLANT RECIPIENTS: 762 Goring, S.; Eyawo, O.; Mills, E. J.; More Goring, S.; Eyawo, O.; Mills, E. J.; Levy, A.; L'Italien, G. J.; Trivedi, D.; Kasiske, B. Less Transplantation. 90:75, July 27, 2010. Favorites PDF Get Content & Permissions Free
OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT): 2857 Vincenti, F.; Grinyó, J. M.; Charpentier, B.; More Vincenti, F.; Grinyó, J. M.; Charpentier, B.; Pestana, J. O.M.; Rostaing, L.; Vanrenterghem, Y.; Lin, C.; Di Russo, G.; Larsen, C. Less Transplantation. 90:175, July 27, 2010. Favorites PDF Get Content & Permissions Free
SAFETY PROFILE OF BELATACEPT IN KIDNEY TRANSPLANT RECIPIENTS FROM A POOLED ANALYSIS OF PHASE II AND PHASE III STUDIES: 1417 Grinyo, J.; Charpentier, B.; Pestana, J. O.M.; More Grinyo, J.; Charpentier, B.; Pestana, J. O.M.; Vanrenterghem, Y.; Vincenti, F.; Shi, R.; Agarwal, M.; Thomas, D.; Larsen, C. Less Transplantation. 90:156, July 27, 2010. Favorites PDF Get Content & Permissions Free
IMMUNOSUPPRESSION WITH BELATACEPT-BASED, CNI-AVOIDING AND STEROID-AVOIDING REGIMENS VS A TACROLIMUS-BASED, STEROID-AVOIDING REGIMEN IN KIDNEY TRANSPLANT PATIENTS: RESULTS OF A 1-YEAR, RANDOMIZED STUDY: 1436 Ferguson, R.; Vincenti, F.; Kaufman, D.; More Ferguson, R.; Vincenti, F.; Kaufman, D.; Woodle, E. S.; Marder, B.; Citterio, F.; Marks, W. H.; Dong, Y.; Agarwal, M.; Garg, P.; Grinyó, J. M. Less Transplantation. 90:156, July 27, 2010. Favorites PDF Get Content & Permissions Free
SWITCH FROM A CNI- TO A BELATACEPT-BASED IMMUNOSUPPRESSIVE REGIMEN IN KIDNEY TRANSPLANT RECIPIENTS IS SAFE AND RESULTS IN BETTER RENAL FUNCTION: 12 MONTH RESULTS FROM A PHASE II STUDY: 1446 Rostaing, L.; Nainan, G.; Rial, M. C.; More Rostaing, L.; Nainan, G.; Rial, M. C.; Steinberg, S.; Vincenti, F.; Shi, R.; Di Russo, G.; Thomas, D.; Grinyó, J. M. Less Transplantation. 90:157, July 27, 2010. Favorites PDF Get Content & Permissions Free
BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY: 1374 Larsen, C.; Grinyó, J. M.; Charpentier, B.; More Larsen, C.; Grinyó, J. M.; Charpentier, B.; Pestana, J. O.M.; Kamar, N.; Vanrenterghem, Y.; Lin, C.; Di Russo, G.; Garg, P.; Vincenti, F. Less Transplantation. 90:158, July 27, 2010. Favorites PDF Get Content & Permissions Free
PHARMACOKINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF BELATACEPT IN RENAL TRANSPLANT PATIENTS: 1870 Shen, J.; Block, A.; Townsend, R.; More Shen, J.; Block, A.; Townsend, R.; You, Xiaoli X.; Shen, Y.; Zhou, S.; Geng, D.; McGirr, N.; Soucek, K.; Pursley, J.; Di Russo, G.; Kaul, S. Less Transplantation. 90:426, July 27, 2010. Favorites PDF Get Content & Permissions Free
APPLICATION OF A VALIDATED LONG-TERM RENAL TRANSPLANT GRAFT SURVIVAL PREDICTION MODEL TO EXPECTED BELATACEPT PHASE III TRIAL OUTCOMES: 679 Schnitzler, M. A.; Trivedi, D.; L'Italien, G. J. Schnitzler, M. A.; Trivedi, D.; L'Italien, G. J. Less Transplantation. 90:341, July 27, 2010. Favorites PDF Get Content & Permissions Free
RELATIONSHIP BETWEEN BELATACEPT EXPOSURE AND CLINICAL ENDPOINTS IN RENAL TRANSPLANT PATIENTS: 1892 Zhou, S.; Roy, A.; Shen, J.; More Zhou, S.; Roy, A.; Shen, J.; Kaul, S.; Pfister, M. Less Transplantation. 90:426, July 27, 2010. Favorites PDF Get Content & Permissions Free
OUTCOMES AS A FUNCTION OF DONOR CRITERIA FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT-EXT): 1773 Florman, S.; Durrbach, A.; Larsen, C.; More Florman, S.; Durrbach, A.; Larsen, C.; Pestana, J. M.; Vanrenterghem, Y.; Vincenti, F.; Block, A.; Garg, P.; Copley, B.; Duan, T.; Grinyó, J. M. Less Transplantation. 90:342, July 27, 2010. Favorites PDF Get Content & Permissions Free
BENEFIT-RISK PROFILE OF THE BELATACEPT LI REGIMEN AT 2 YEARS IN EBV(+) KIDNEY TRANSPLANT RECIPIENTS: 3370 Vincenti, F.; Grinyo, J.; Larsen, C.; More Vincenti, F.; Grinyo, J.; Larsen, C.; Pestana, J. O.M.; Vanrenterghem, Y.; Duan, T.; Agarwal, M.; Charpentier, B. Less Transplantation. 90:649, July 27, 2010. Favorites PDF Get Content & Permissions Free
